- Home
- EVTV vs ONCO Comparison
EVTV vs ONCO Comparison
Compare EVTV & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTV
- ONCO
- Stock Information
- Founded
- EVTV 2012
- ONCO 2018
- Country
- EVTV United States
- ONCO United States
- Employees
- EVTV N/A
- ONCO N/A
- Industry
- EVTV Auto Manufacturing
- ONCO Biotechnology: Pharmaceutical Preparations
- Sector
- EVTV Consumer Discretionary
- ONCO Health Care
- Exchange
- EVTV Nasdaq
- ONCO Nasdaq
- Market Cap
- EVTV 6.4M
- ONCO 9.4M
- IPO Year
- EVTV 2017
- ONCO 2022
- Fundamental
- Price
- EVTV $0.35
- ONCO $0.54
- Analyst Decision
- EVTV
- ONCO
- Analyst Count
- EVTV 0
- ONCO 0
- Target Price
- EVTV N/A
- ONCO N/A
- AVG Volume (30 Days)
- EVTV 3.3M
- ONCO 9.9M
- Earning Date
- EVTV 03-27-2025
- ONCO 04-10-2025
- Dividend Yield
- EVTV N/A
- ONCO N/A
- EPS Growth
- EVTV N/A
- ONCO N/A
- EPS
- EVTV N/A
- ONCO N/A
- Revenue
- EVTV $1,730,010.00
- ONCO $1,870,605.00
- Revenue This Year
- EVTV N/A
- ONCO N/A
- Revenue Next Year
- EVTV N/A
- ONCO N/A
- P/E Ratio
- EVTV N/A
- ONCO N/A
- Revenue Growth
- EVTV N/A
- ONCO N/A
- 52 Week Low
- EVTV $0.29
- ONCO $0.32
- 52 Week High
- EVTV $3.20
- ONCO $21.40
- Technical
- Relative Strength Index (RSI)
- EVTV 23.91
- ONCO 43.36
- Support Level
- EVTV $0.32
- ONCO $0.53
- Resistance Level
- EVTV $0.37
- ONCO $0.70
- Average True Range (ATR)
- EVTV 0.08
- ONCO 0.06
- MACD
- EVTV 0.01
- ONCO 0.00
- Stochastic Oscillator
- EVTV 11.90
- ONCO 15.40
About EVTV Envirotech Vehicles Inc.
Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.